Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease

Table 2 Specific injury according to the acute on chronic liver failure type n (%)

	Type A	Type B	Type C	P value
HBV flareace	17 (50.0)	11 (20.8)	4 (5.0)	< 0.001
Alcoholae	3 (8.8)	19 (35.9)	6 (7.5)	< 0.001
HAV	3 (8.8)	1 (1.9)	1 (1.3)	0.130
Toxine	5 (14.7)	9 (17.0)	3 (3.8)	0.021
AIH flarec	7 (20.6)	2 (3.8)	0 (0.0)	< 0.001
Infectionac	0 (0.0)	13 (24.5)	32 (40.0)	< 0.001
Varix bleeding	0 (0.0)	3 (5.7)	11 (13.8)	0.035
Other bleeding	0 (0.0)	2 (3.8)	6 (7.5)	0.215
Unknowne	4 (11.8)	4 (7.6)	23 (28.8)	0.005

^aP < 0.05, Type A vs B using Bonferroni’s post hoc test;

^cP < 0.05 Type A vs C using Bonferroni’s post hoc test;

^eP < 0.05 Type B vs C using Bonferroni’s post hoc test. HBV: Hepatitis B virus; HAV: Hepatitis A virus; AIH: Autoimmune hepatitis.